[go: up one dir, main page]

TR201717703A2 - APIXABAN FORMULATIONS - Google Patents

APIXABAN FORMULATIONS Download PDF

Info

Publication number
TR201717703A2
TR201717703A2 TR2017/17703A TR201717703A TR201717703A2 TR 201717703 A2 TR201717703 A2 TR 201717703A2 TR 2017/17703 A TR2017/17703 A TR 2017/17703A TR 201717703 A TR201717703 A TR 201717703A TR 201717703 A2 TR201717703 A2 TR 201717703A2
Authority
TR
Turkey
Prior art keywords
apixaban
formulations
apixaban formulations
prevention
pharmaceutically acceptable
Prior art date
Application number
TR2017/17703A
Other languages
Turkish (tr)
Inventor
Ünlü Serdar
Şahi̇n Yasemi̇n
Muhi̇bbi̇ Işik Murat
Soyer Can Okşan
Göçmentürk Mustafa
Eryalçin Özlem
Kazaz Çağla
Original Assignee
Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Ali Raif Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/17703A priority Critical patent/TR201717703A2/en
Publication of TR201717703A2 publication Critical patent/TR201717703A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş apiksaban veya farmasötik olarak kabul edilebilir bir tuzunu içeren oral farmasötik formülasyonlar için üretim yöntemine ve bu yöntemle üretilen formülasyonların tromboembolik hastalıkların önlenmesinde ve/veya tedavi edilmesinde kullanılmasına ilişkindir.The present invention relates to a production method for oral pharmaceutical formulations containing apixaban or a pharmaceutically acceptable salt thereof, and the use of formulations produced by this method in the prevention and / or treatment of thromboembolic diseases.

TR2017/17703A 2017-11-10 2017-11-10 APIXABAN FORMULATIONS TR201717703A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2017/17703A TR201717703A2 (en) 2017-11-10 2017-11-10 APIXABAN FORMULATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/17703A TR201717703A2 (en) 2017-11-10 2017-11-10 APIXABAN FORMULATIONS

Publications (1)

Publication Number Publication Date
TR201717703A2 true TR201717703A2 (en) 2019-05-21

Family

ID=67954923

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/17703A TR201717703A2 (en) 2017-11-10 2017-11-10 APIXABAN FORMULATIONS

Country Status (1)

Country Link
TR (1) TR201717703A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022010437A1 (en) * 2020-07-07 2022-01-13 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A tablet comprising apixaban
WO2022115052A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Improved wet granulation processes for apixaban comprising formulations
WO2022115051A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Direct compression method for non-micronised apixaban formulations

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022010437A1 (en) * 2020-07-07 2022-01-13 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A tablet comprising apixaban
WO2022115052A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Improved wet granulation processes for apixaban comprising formulations
WO2022115051A1 (en) 2020-11-27 2022-06-02 Santa Farma Ilac Sanayii A.S. Direct compression method for non-micronised apixaban formulations

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
MX2024010140A (en) NEW METHODS.
NZ762034A (en) Human plasma kallikrein inhibitors
JO3122B1 (en) Derivatives of Astra-1,3,5 (10), 16-Tetraine-3-carboxamide, preparations, pharmaceutical preparations, and use for the preparation of drugs
MA39765A (en) Pharmaceutical formulations of a pan-raf kinase inhibitor, processes for their preparation, and methods of use
MX394123B (en) AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHODS OF USING THEM
MX387731B (en) ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE.
TR201819805T4 (en) FLAVAGLIN DERIVATIVES.
EA201692111A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES
EA201691796A1 (en) N-SUBSTITUTED ASYMMETRIC UREA AND THEIR APPLICATION IN MEDICINE
EA201692020A1 (en) PROTECTIVE MEANS OF AMERICA ACID FOR APPLICATION IN THE TREATMENT OF LACTOACIDOSIS OR INDIVIDUAL BY MEDICINAL MEANS OF THE DIFFERENT ACTION DUE TO THE COMPLEX I AND OXIDATIVE DISORDERS OF OXIDATIVE CHEMICAL REFERENCES AGREES
EA202090913A1 (en) COMPOSITION OF MODIFIED RELEASE TABLETS CONTAINING MIRABEGRON
TR201717703A2 (en) APIXABAN FORMULATIONS
PH12016502568A1 (en) Novel heterocyclic compound
CY1123394T1 (en) PHARMACEUTICAL COMPOSITION
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
EA201892842A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
TR201713325A2 (en) PRODUCTION METHOD FOR FORMULATIONS CONTAINING RIVAROXABAN
TR201713326A2 (en) Production Method for Formulations Containing Rivaroxaban
EA202091127A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING SAFINAMIDE
MX375329B (en) 2,2,2-TRIFLUOROETIL-THIADIAZINES.
TR201719926A2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PHARMACEUTICALLY ACCEPTABLE LITHIUM SALTS AND VITAMIN C
EA201892675A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING ETHEPLIRSEN
EA201790387A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE DENTAL PAIN OR PAIN JAW